Ticagrelor Induced Angioedema Following Carotid Artery Stenting.
Ahmed ElmashadDanison EmmersonAllison GorsethMatthew N JaffaPublished in: The Neurohospitalist (2022)
Ticagrelor is a frequent component of dual antiplatelet therapy (DAPT) following carotid artery stent placement. Hemorrhagic complications remain the focus of most reports, however, other adverse events must also be known to the prescribing physician. Angioedema is a rare and potentially life-threatening complication reported following ticagrelor administration and we present 1 such case here with a review of the existing literature.
Keyphrases
- antiplatelet therapy
- acute coronary syndrome
- percutaneous coronary intervention
- primary care
- angiotensin converting enzyme
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- systematic review
- coronary artery disease
- emergency department
- adverse drug
- diabetic rats
- high glucose
- risk factors
- angiotensin ii
- drug induced
- atrial fibrillation
- oxidative stress
- ultrasound guided
- endothelial cells